Literature DB >> 19606495

Sequence contexts that determine the pathogenicity of base substitutions at position +3 of donor splice-sites.

Sandie Le Guédard-Méreuze1, Christel Vaché, Nicolas Molinari, Julie Vaudaine, Mireille Claustres, Anne-Françoise Roux, Sylvie Tuffery-Giraud.   

Abstract

Variations at position +3 of 5' splice-sites (5'ss) are reported to induce aberrant splicing in some cases but not in others suggesting that the overall nucleotidic environment can dictate the extent to which 5'ss are correctly selected. Functional studies of three variations identified in donor splice-sites of USH2A and PCDH15 genes sustain this assumption. To gain insights into this question, we compared the nucleotidic context of U2-dependent 5'ss naturally deviated (+3G,+3C, or+3T) from the+3A consensus with 5'ss for which a +3 variation (A>G, A>C, or A>T) was shown to induce aberrant splicing. Statistical differences were found between the two datasets, highlighting the role of one peculiar position in each context (+3G/+4A; +3C/-1G; and +3T/-1G). We provided experimental support to the biostatistical results through the analysis of a series of artificial mutants in reporter minigenes. Moreover, different 5' end-mutated U1 snRNA expression plasmids were used to investigate the importance of the position +3 and of the two identified compensatory positions -1 and +4 in the recognition of 5'ss by the U1 snRNP. Overall, our findings establish general properties useful to molecular geneticists to identify nucleotide substitutions at position +3 that are more likely to alter splicing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19606495     DOI: 10.1002/humu.21070

Source DB:  PubMed          Journal:  Hum Mutat        ISSN: 1059-7794            Impact factor:   4.878


  9 in total

1.  A Reporter Based Cellular Assay for Monitoring Splicing Efficiency.

Authors:  Jason Wong; William Martelly; Shalini Sharma
Journal:  J Vis Exp       Date:  2021-09-15       Impact factor: 1.424

2.  Intron retention resulting from a silent mutation in the VWF gene that structurally influences the 5' splice site.

Authors:  Hamideh Yadegari; Arijit Biswas; Mohammad Suhail Akhter; Julia Driesen; Vytautas Ivaskevicius; Natascha Marquardt; Johannes Oldenburg
Journal:  Blood       Date:  2016-08-19       Impact factor: 22.113

3.  FUBP1: a new protagonist in splicing regulation of the DMD gene.

Authors:  Julie Miro; Abdelhamid Mahdi Laaref; Valérie Rofidal; Rosyne Lagrafeuille; Sonia Hem; Delphine Thorel; Déborah Méchin; Kamel Mamchaoui; Vincent Mouly; Mireille Claustres; Sylvie Tuffery-Giraud
Journal:  Nucleic Acids Res       Date:  2015-02-06       Impact factor: 16.971

Review 4.  Interpretation of mRNA splicing mutations in genetic disease: review of the literature and guidelines for information-theoretical analysis.

Authors:  Natasha Caminsky; Eliseos J Mucaki; Peter K Rogan
Journal:  F1000Res       Date:  2014-11-18

5.  Stem-loop 4 of U1 snRNA is essential for splicing and interacts with the U2 snRNP-specific SF3A1 protein during spliceosome assembly.

Authors:  Shalini Sharma; Somsakul Pop Wongpalee; Ajay Vashisht; James A Wohlschlegel; Douglas L Black
Journal:  Genes Dev       Date:  2014-11-15       Impact factor: 11.361

6.  A +3 variant at a donor splice site leads to a skipping of the MYH11 exon 32, a recurrent RNA defect causing Heritable Thoracic Aortic Aneurysm and Dissection and/or Patent Ductus Arteriosus.

Authors:  Bertrand Chesneau; Aurélie Plancke; Guillaume Rolland; Bertrand Marcheix; Yves Dulac; Thomas Edouard; Julie Plaisancié; Marion Aubert-Mucca; Sophie Julia; Maud Langeois; Thierry Lavabre-Bertrand; Philippe Khau Van Kien
Journal:  Mol Genet Genomic Med       Date:  2021-10-21       Impact factor: 2.183

7.  Functional assays of non-canonical splice-site variants in inherited retinal dystrophies genes.

Authors:  Ana Rodriguez-Muñoz; Alessandro Liquori; Belén García-Bohorquez; Teresa Jaijo; Elena Aller; José M Millán; Gema García-García
Journal:  Sci Rep       Date:  2022-01-07       Impact factor: 4.379

8.  Experience of targeted Usher exome sequencing as a clinical test.

Authors:  Thomas Besnard; Gema García-García; David Baux; Christel Vaché; Valérie Faugère; Lise Larrieu; Susana Léonard; Jose M Millan; Sue Malcolm; Mireille Claustres; Anne-Françoise Roux
Journal:  Mol Genet Genomic Med       Date:  2013-07-10       Impact factor: 2.183

9.  Combined genetic approaches yield a 48% diagnostic rate in a large cohort of French hearing-impaired patients.

Authors:  D Baux; C Vaché; C Blanchet; M Willems; C Baudoin; M Moclyn; V Faugère; R Touraine; B Isidor; D Dupin-Deguine; M Nizon; M Vincent; S Mercier; C Calais; G García-García; Z Azher; L Lambert; Y Perdomo-Trujillo; F Giuliano; M Claustres; M Koenig; M Mondain; A F Roux
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.